Biocomposites Introduces NanoBone Products to the UK Market
Biocomposites has unveiled its exciting new NanoBone product line in the UK, focusing on cutting-edge osteoinductive bone grafts. These innovative products are crafted from patented nanostructured hydroxyapatite, which plays a crucial role in bone remodeling.
Presenting NanoBone at Key Events
The launch of NanoBone comes at a significant moment as Biocomposites is set to feature these products at an important orthopaedic conference. The British Orthopaedic Association's Annual Congress offers an ideal opportunity to present this groundbreaking technology and connect with industry professionals, reinforcing Biocomposites’ dedication to surgical innovation.
Insights into the NanoBone Range
The NanoBone line encompasses products like NanoBone SBX Putty and NanoBone QD. These offerings support reliable early osteogenesis, facilitating efficient bone formation. Designed specifically for the fast-paced environment of surgical procedures, these synthetic bone grafts are essential tools for many healthcare professionals.
Grasping the Technology Behind NanoBone
NanoBone's unique formulation includes nanostructured hydroxyapatite suspended in a silica gel matrix, all within a hydrogel/polymer silica carrier. This advanced technology not only supports bone regeneration but also maintains healing rates on par with autografts. It notably avoids the complications and expenses linked to harvesting bone grafts from other body sites.
Commitment to Quality and Integration
Produced by Biocomposites GmbH, a reputable name in the development of innovative bone graft substitutes, NanoBone marks a significant advancement in the company’s mission to enhance surgical outcomes. Since acquiring Biocomposites GmbH, the company has successfully integrated and improved the NanoBone range, ensuring it meets the stringent standards of today's medical practices.
Biocomposites’ Global Presence
Biocomposites works with a global focus, extending its reach across multiple markets worldwide. Their operations cover regions including Europe, South America, the USA, and Asia, establishing the company as a leader in developing calcium compounds tailored for surgical uses. With over 1 million procedures utilizing Biocomposites products each year, the effectiveness and demand for these innovative solutions are clear.
Enhancing Patient Care
Dr. Walter Gerike, Managing Director of Biocomposites GmbH, notes that NanoBone has a strong track record, having assisted more than 100,000 patients globally. The UK launch represents a vital opportunity, and the availability of this ready-to-use product line is anticipated to significantly expand surgical options, ultimately improving patient care.
About Biocomposites
Biocomposites is an international medical device company focused on the engineering and production of high-quality products aimed at managing infections in bone and soft tissue. With a robust presence in regions like North America and Asia, Biocomposites leads the way in innovative healthcare solutions. By concentrating on developing products that regenerate bone and reduce infection risks across orthopaedics and trauma specialties, the company continues to set high standards in the medical industry.
Frequently Asked Questions
What does the NanoBone product range include?
The NanoBone product range includes advanced osteoinductive bone grafts such as NanoBone SBX Putty and NanoBone QD, designed to support bone regeneration effectively.
Where is NanoBone being launched?
NanoBone is being launched in the UK, and it will be featured at the British Orthopaedic Association's Annual Congress.
Who is responsible for manufacturing NanoBone?
NanoBone is manufactured by Biocomposites GmbH, a company that specializes in developing innovative bone graft substitutes.
How does the technology of NanoBone function?
NanoBone harnesses nanostructured hydroxyapatite in a silica gel matrix, which aids in bone regeneration while achieving healing rates similar to those of autografts.
What is the mission of Biocomposites?
Biocomposites is dedicated to creating advanced medical solutions for managing infections in bone and soft tissue, striving to improve surgical outcomes around the globe.
